Scientists hunt for hidden weakness in lung cancer
NCT ID NCT07303218
Summary
This study aims to understand how common a specific DNA repair problem is in people with a certain type of advanced lung cancer (EGFR-mutated NSCLC). Researchers will look at tissue samples from 100 patients to see if having this problem is linked to how patients fare and if it might make the cancer more sensitive to a specific class of drugs called PARP inhibitors. The goal is to gather knowledge that could help guide future, more personalized treatment strategies.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON-SMALL CELL LUNG CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Dept. Medical Oncology
Milan, MI, 20132, Italy
Conditions
Explore the condition pages connected to this study.